Diligence memo · auto-generated · as of July 2, 2026
Isis Pharmaceuticals Inc
Isis Pharmaceuticals Inc has raised $201M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Isis Pharmaceuticals Inc operates in Pharmaceuticals, based in CARLSBAD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Isis Pharmaceuticals Inc has raised $201M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $201M on 2012-08-13.
Most recent recorded round closed around 2012-08-13.
Valuation (modeled)modeled
Provath models Isis Pharmaceuticals Inc at approximately $7.1B (range $958M–$15.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 13.9 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 96% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 99% of those peers.
Closest niche peers: Radius Health, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.